TRENTON, N.J., Dec. 08, 2016 -- In response to the proposed surgical declawing ban now before the New Jersey Assembly (A3899) and the Senate (S2410), the New Jersey Veterinary Medical Association (NJVMA) launched a public campaign at LoveYourCats.org opposing the increased euthanasia that would certainly result from a surgical declawing ban.
Surgical declawing with advanced pain control methods is recommended by doctors as a last resort, as an alternative to euthanasia or abandonment.
“We want to see cats in loving, caring households,” says Dr. Michael Yurkus of the NJVMA. “We know that 72% of all cats sent to shelters will be euthanized, and this is a 100% preventable tragedy. As the leading advocates for saving the lives of unwanted or discarded animals, we’re laying out the vital facts and calling on concerned citizens to oppose this legislation at LoveYourCats.org.”
While veterinarians have reduced declawing through better education regarding the alternatives, the NJVMA is especially concerned for cats living with people taking immunity suppressing medication or blood thinners, or people with blood disorders, where an animal scratch would pose a health risk. Also of concern are the cats living with the elderly in facilities that require cats to be declawed.
About the New Jersey Veterinary Medical Association (NJVMA)
Founded in 1884 as a professional association representing the state’s 1,600 licensed veterinarians, the NJVMA is dedicated to advancing the veterinary profession in New Jersey, protecting the health of animals and extending progressive leadership in the research, care, treatment, and welfare of animals. The NJVMA encourages high ethical standards and competence in the treatment of animals and promotes excellence in the professional training and continuing education of doctors of veterinary medicine. The association is a nexus point for all the issues, factors, and organizations that will have an impact on New Jersey’s veterinarians. For more information, go to www.njvma.org
Contact Karen Geisel at (518) 421-3435


Britain Courts Anthropic Amid US Defense Department Dispute
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Apple Turns 50: From Garage Startup to AI Crossroads
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 



